4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-030661
President and Head of R&D bought 5,000 shares at $0.68 ($3,400)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nagendran Sukumar President and Head of R&D | 2023-05-16 | Purchase | +5,000 | $0.68 | $3,400 | 34,226 | D |
| Open-market purchases · 5,000 sh · avg $0.68 · $3,400 | |||||||
Loading xslF345X04/doc4.xml…